Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Continuous Pumping + Chemo in Advanced NSCLC
NCT02513355Phase 4Unknown
- Sponsor
- Nanjing Ningqi Pharmaceutical Technology
- Start
- Feb 2015
- Primary completion
- Nov 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Nanjing Ningqi Pharmaceutical Technology. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02513355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513355.